Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Activated charcoal for prevention of irinotecan-induced diarrhea in FOLFIRI (advanced colorectal cancer)
TCTR20240615003Phase 2Unknown
- Sponsor
- Rajavithi Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of activated charcoal in colorectal cancer (CRC), sponsored by Rajavithi Hospital. Status: unknown.
02
Drugs
activated charcoal
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on TCTR20240615003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240615003.